Locations:
Search IconSearch
October 21, 2022/Neurosciences

Cross-Disciplinary Pain Management in Spine Surgery

A surgeon’s perspective: three patient groups

spine surgery pain management

For spine surgery to succeed, the procedure must work and the hardware must function. Success requires that the surgery itself goes well, yet the mechanics are just part of the equation.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The successful management of pain also determines whether spine surgery improves a patient’s quality of life. From a surgeon’s perspective, odds are greatly enhanced by a nuanced understanding of the patient’s pain history, partnering with colleagues in pain management, and the use of Enhanced Recovery After Surgery (ERAS®) techniques. This approach has the best chance of minimizing opiates, maximizing patient satisfaction, expediting recovery and preventing surgeries from being done on those unlikely to benefit, says Michael Steinmetz, MD, Chairman of Cleveland Clinic’s Department of Neurosurgery.

This more holistic approach is relatively new — a result of the national opioid crisis and the introduction of revised regulations.

“It used to be that you’d operate on somebody and give them enough pain pills afterward so that they were comfortable,” Dr. Steinmetz says. “With the new regulations, we were able only to give small amounts of opiates, even after surgery, and for very specific reasons. We had to refocus our approach.”

Physicians’ concerns that reducing reliance on opioids would lead to patient suffering and dissatisfaction have not been borne out, and the turn toward multimodal pain treatment has yielded positive outcomes.

“We’ve started to see that things have changed,” Dr. Steinmetz adds. “We don’t have as many patients coming in (for surgeries) on chronic opioids, although they still come in, and our goal is to get them off fairly quickly afterward. It’s been a frame shift in the surgical approach to these patients. We are much more thoughtful about the process today than we’ve ever been.”
Dr. Steinmetz identifies three spine patient groups that call for distinct approaches.

Advertisement

Group 1: opioid-naive patients who do not have chronic pain

Group 1 patients typically are suffering acute events, such as a herniated disk or pain from stenosis, and have never taken opioids.

“We’ll operate on them and try to get them back to their lives,” says Dr. Steinmetz. “We should be able to give them a small amount of opiates and get them off them fairly quickly.”

Opioid-minimizing efforts begin during the preoperative period. “Before these patients come up to surgery, they’re getting a bolus of Tylenol and gabapentin,” says Dr. Steinmetz. “The anesthesiologists try to use agents outside of opiates, like epidural blocks, in and around the time of surgery to try to prevent pain afterward. We inject liposomal bupivacaine. We do everything we can before surgery, during surgery and after surgery using multimodal, opiate-sparing strategies.”

Group 2: patients who do not have a pain disorder but have been taking opioids

Group 2 patients also tend to have common lower-back pathologies, but they have been taking opioids.

“I might see somebody who has had lumbar spinal stenosis and leg pain for six months, and their primary care doctor has put them on low-dose opioids,” says Dr. Steinmetz. “This is not somebody who truly has a psychological chronic pain disorder, but because they’re coming in on opioids, this is a challenging patient.”

Opioid history is an independent predictor of poor outcomes after all types of spine surgery, says Dr. Steinmetz. Often the drug is treating or masking depression, anxiety or other life stressors – conditions that can complicate pain management and hinder recovery. And if opiate use is not carefully handled, this patient risks developing ongoing drug dependency.

Advertisement

“We have to deal with that patient differently than the first patient,” he says.

ERAS protocols help. They include preoperative education for the patient and family, physiological and psychological optimization, multimodal analgesia, limited postsurgical use of narcotics, and training in nonpharmacological methods for managing pain. “ERAS is a multidisciplinary, multimodal approach to reduce surgical stress response, length of hospital stay and complications, all while improving the patient’s time to get out of the hospital and into rehab and recovery,” says Dr. Steinmetz. “ERAS is not specific to spine or pain management, but it has been shown to be cost-effective, safe and beneficial, and we apply that in the spine world.”

Group 3: patients with chronic pain syndrome

Pathologies among members of this group are likely to be more complicated and include failed back surgery syndrome, previous back surgeries and perhaps deformities, such as scoliosis. “These are people who have had back pain every day, all day long, and can’t get away from the pain. They have a psychological issue with this,” he says. “They’re often on high-dose opiates, they aren’t able to work, and they tend to be heavy smokers. Their life is pain.”

The profile can also include young people who have had multilevel fusions. “Never for one minute of the day did they get better from these operations,” he says. “And then they had four other surgeries since then.”

Yet often these patients often show up with the hope that just one more surgery will fix their pain.

Advertisement

Psychological distress is a defining factor in group 3 patients. And while these patients also may well have a problem that can be addressed with surgery, says Dr. Steinmetz, they may not be ideal candidates for surgery unless they can be physically and psychologically optimized. “Everything is more challenging with them, such as treating their pain afterwards,” he says. “They need much higher dosages. We’ve got to partner with our pain management colleagues, and these patients need some psychological treatment ahead of time as well.”

Partnerships provide a path forward

All three patient groups benefit from presurgical optimization, including management of expectations about postsurgical pain. A two-hour, clinician-led online class for spine patients, called TREK for Surgical Success, is based on ERAS principles, and is designed specifically for spine-surgery patients.

But for those experiencing depression, anxiety and other psychological issues, the best opportunity for good outcomes depends on a multimodal approach that begins with specialists in pain psychology.

“You can’t just throw painkillers at someone who has psychological distress and expect them to be happier with their hospital care,” Dr. Steinmetz says. “We need to use things like music therapy and physical therapy. We can reduce opiates and keep patients satisfied, and in fact throwing opiates at them does not make them happier.”

Cleveland Clinic’s Back on TREK program tailors such care for patients with chronic pain. Back on TREK can take up to 10 weeks, depending on patient variables.

Advertisement

“In the past, we might see these patients and say ‘I’m a surgeon, and you have chronic pain. I’m sending you to pain psychology,’ and that was it,” says Dr. Steinmetz. “Now we say, ‘Maybe you do need surgery. But let’s partner with pain management and with psychology. We going to optimize you for a successful surgery.’ So it’s a true partnership.”

Setting appropriate expectations is essential, he adds.

“We try to steer away from saying, ‘I’m going to make you pain free.’ The goal is to try to get the patient back into a functional existence again. With the help of pain management and surgery, we can make that happen.

“When all of that comes together, I think we can do a pretty good job on these patients when we choose to operate,” says Dr. Steinmetz.

Related Articles

Two people working in a community garden
Rehabilitation: Beyond Recovery, Toward Renewed Participation

Tasked-based therapy improves social connection and quality of life

gloved hand holding blood vial with neuropathology slide in background
October 10, 2025/Neurosciences/Epilepsy
Blood-Based Epigenetic Biomarkers Differentiate Focal Cortical Dysplasia Subtypes

Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis

young man using walking canes on a city street
Vidofludimus for Progressive MS: No Impact on Brain Atrophy but Hints of a Role for Disability

Mixed results from phase 2 CALLIPER trial of novel dual-action compound

illustration of myelin sheaths wrapped around neuron axons
Revised McDonald Criteria for Multiple Sclerosis: A Big Step Toward Biomarker-Driven Diagnosis

A co-author of the new recommendations shares the updates you need to know

Dr. Jason Savage against a decorative background with podcast button overlay
October 2, 2025/Neurosciences/Podcast
Essentials of Revision Spine Deformity Surgery (Podcast)

Success for these complex operations requires judicious patient selection and presurgical patient optimization

physician talking with a patient in medical office
De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at Outcomes

Rebound risk is shaped by patient characteristics and mechanism of action of current DMT

woman speaking to a doctor
Tool Shows Promise for Individualized Decision Support on Stopping Disease-Modifying Therapy for Multiple Sclerosis

First-of-kind prediction model demonstrates high consistency across internal and external validation

health worker preparing infusion of injectable drug
Ocrelizumab Associated With Nearly Twofold Increase in Serious Infections Vs. Platform Injectables in Multiple Sclerosis

Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age

Ad